// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

How often are Core Variables Required to Calculate Common Disease Activity Scores Measured in the Routine Care of Rheumatoid Arthritis Patients?

Binu Jacob - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Comparing Drug Survival between Five Tumor Necrosis Factor Inhibitors in Patients with Psoriatic Arthritis

Tiffany Got - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

Validation of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and Effectiveness of Infliximab in the Treatment of Ankylosing Spondylitis over 4 Years: The Canadian Experience

Denis Choquette - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

Infliximab

Impact of Adherence to Treat-to-Target of Rheumatoid Arthritis in Real World Practice: Data from the International RA BIODAM Program

Carter Thorne - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Survey of Practice Patterns in the Diagnosis and Management of Systemic Lupus Erythematosus in Canada

Sasha Bernatsky - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Characterizing T cell Profiles in Patients with Ankylosing Spondylitis

Eric Gracey - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

lonomycin

Adherence to RA Medications as Reported by Patients and Rheumatologists in the Ontario Best Practices Research Initiative (OBRI)

Xiuying Li - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

What is the Internal Consistency of the Disease Activity Score (DAS)-28 in Rheumatoid Arthritis Patients Treated in a RealWorld Setting?

Andrew Chow - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Infliximab

Use of MEDSCHECK Program Among Rheumatoid Arthritis Patients Results from Ontario Best Practice Research Initiative (OBRI)

Apoorva Kelkar - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

All-Cause Mortality for Patients with Rheumatoid Arthritis in a Universal Public Health Care System

Michael Paterson - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Cigarette Smoking and Disease Activity in Rheumatoid Arthritis Patients: Results from Ontario Best Practice Research Initiative (OBRI)

George Tomlinson - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

The Implementation of Ottawa Panel Evidence-Based Clinical Practice Guidelines for Aerobic Walking Programs in the Management of Osteoarthritis: The PEP (Participant Exercise Preference) Study

Gino De Angelis - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Eosinophilic Cystitis: A Case Report and Review of the Literature

Elaine Yacyshyn - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Methods Used in Standardizing Drug Names: Experience from OBRI Study

Binu Jacob - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Ankylosing Spondylitis Remission with Imatinib

Stephen Nantel - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Imatinib

Serological Analysis of Patients with Positive Anti-CCP Antibodies Referred through a Rheumatology Triage System

Whitney Steber - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Low Socioeconomic Status (SES) as Measured by Education is Not Predictive of Poor Patient Outcomes in Systemic Lupus Erythematosus (SLE): Data from the 1000 Canadian Faces of Lupus

Janet Pope - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Bisphosphonates for Steroid-Induced Osteoporosis: A Meta-Analysis

Claire Allen - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Ergocalciferol

The Knowledge-To-Action Cycle (KTAC): A Canadian Model to Guide the Dissemination and the Implementation of the Bilingual People Getting a Grip on Arthritis Self-Management Program

George Wells - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

The Non Pharmacological Management of Osteoarthritis & Rheumatoid Arthritis

Karine Toupin-April - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Rheumatoid arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved